drugset / Trial / NCT00218322
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
Phase 4
Completed
108 enrolled
Massachusetts General Hospital
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Adolescents with attention deficit hyperactivity disorder (ADHD) often develop substance use disorders (SUD). The purpose of this study is to evaluate the effectiveness of atomoxetine in treating adolescents dually diagnosed with ADHD and SUD.
Timeline
- Start
- 2004-09
- Primary completion
- 2006-03
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atomoxetine | Other / unclassified | 40 mg | — |
| Subject | Atomoxetine | Other / unclassified | 100 mg | — |